查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1938696

2026年全球狂犬病诊断市场报告

Rabies Diagnostics Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，狂犬病诊断市场规模大幅扩大，预计将从2025年的17.8亿美元成长到2026年的18.9亿美元，复合年增长率为6.6%。过去几年的成长可归因于动物狂犬病的高发生率、人们对狂犬病预防意识的提高、兽医诊断检查室的增加、政府在狂犬病控制方面的倡议以及诊断剂和试剂盒的进步。

预计未来几年狂犬病诊断市场规模将强劲成长，2030年将达到24.5亿美元，复合年增长率（CAGR）为6.7%。预测期内的成长可归因于人工智慧诊断工具的普及、对快速就地检验的增加、行动端疾病监测的扩展、分子和血清学技术的创新，以及公私合营在消除狂犬病方面的加强。预测期内的关键趋势包括：快速照护现场狂犬病检测、先进的分子诊断技术、人工智慧在狂犬病检测中的应用、行动端狂犬病监测解决方案以及高灵敏度血清学检测。

狂犬病日益普遍预计将推动狂犬病诊断市场的成长。狂犬病是一种可预防的病毒性疾病，最常见的传播途径是被患有狂犬病的动物咬伤。该病毒会攻击哺乳动物的中枢神经系统，最终导致脑损伤和死亡。狂犬病诊断透过各种检测和技术来检测人类和动物体内是否存在狂犬病毒。此外，动物传播感染疾病的日益增加也进一步推动了对狂犬病诊断的需求。例如，根据美国政府机构南达科他州卫生部（SD DOH）的数据，截至2024年4月，该州2023年共有20隻动物狂犬病检测呈阳性，比2022年的9例增加了122%。在这些感染狂犬病的动物中，1隻为家畜（牛），其余19隻为野生动物（包括18隻蝙蝠和1隻臭鼬）。因此，狂犬病日益普遍预计将推动狂犬病诊断市场的发展。

为了维持市场地位，狂犬病诊断市场的主要企业正在开发创新产品，例如狂犬病抗体检测套组。狂犬病抗体检测套组是一种诊断工具，用于检测血液中的抗体，以评估免疫状态和是否需要加强狂犬病疫苗接种。例如，2024年2月，美国诊断公司BioStone Animal Health推出了「AsurDx」试剂盒。本试剂盒采用快速、高灵敏度的ELISA方法检测哺乳动物血清中狂犬病毒特异性抗体。它为评估已接种疫苗动物和高风险动物的狂犬病免疫力提供了一种经济有效的解决方案。此试剂盒操作简便，结果可靠，并保证符合0.5国际单位（IU）/毫升的狂犬病保护性免疫标准。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球狂犬病诊断市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 人工智慧（AI）和自主人工智慧
    • 数位化、云端运算、巨量资料、网路安全
    • 物联网、智慧基础设施和互联生态系统
    • 工业4.0和智慧製造
  • 主要趋势
    • 快速现场狂犬病检测
    • 先进的分子诊断技术
    • 将人工智慧应用于狂犬病检测
    • 基于行动装置的狂犬病监测解决方案
    • 高灵敏度血清学检测

第五章 终端用户产业市场分析

  • 医院
  • 诊断中心
  • 癌症安宁疗护诊所
  • 研究所
  • 兽医诊所

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球狂犬病诊断市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球狂犬病诊断市场规模、比较及成长率分析
  • 全球狂犬病诊断市场表现：规模与成长，2020-2025年
  • 全球狂犬病诊断市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 透过诊断方法
  • 萤光抗体检测、免疫组织化学、扩增法、组织学、血清学
  • 透过技术
  • 酵素连结免疫吸附试验（ELISA）或免疫组织化学、层析法技术、聚合酶炼式反应（PCR）及其他技术
  • 最终用户
  • 医院、诊断中心、癌症安宁疗护诊所和其他最终用户
  • 按类型细分：萤光
  • 直接萤光抗体检测（DFA）
  • 按类型细分：免疫组织化学
  • 酵素免疫分析法（ELISA）、蛋白质印迹法
  • 按类型细分：扩增方法
  • 聚合酵素链锁反应（PCR）、逆转录聚合酵素链锁反应（RT-PCR）
  • 按类型细分：组织学检查
  • 显微镜检查、组织染色
  • 按类型细分：血清学检测
  • 病毒中和试验（VNT）、酵素免疫分析法（ELISA）

第十章 区域与国家分析

  • 全球狂犬病诊断市场：依地区、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测
  • 全球狂犬病诊断市场：按国家、绩效和预测划分，2020-2025 年、2025-2030 年预测、2035 年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 狂犬病诊断市场：竞争格局与市场份额，2024 年
  • 狂犬病诊断市场：公司估值矩阵
  • 狂犬病诊断市场：公司简介
    • Bio-Rad Laboratories Inc.
    • The Merck Group
    • Aviva Systems Biology Corporation
    • Creative Diagnostics
    • Demeditec Diagnostics GmbH

第37章：其他领先和创新企业

  • Abbexa Ltd., Norgen Biotek Corp., BioNote Inc., Express Biotech International Inc., MyBioSource Inc., QIAGEN NV, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies Inc., Fluidigm Corp., Bio-X Diagnostics SA, Fujirebio Diagnostics Inc., Gold Standard Diagnostics Corp., Heska Corporation, IDEXX Laboratories Inc.

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年狂犬病诊断市场：提供新机会的国家
  • 2030年狂犬病诊断市场：新兴细分市场机会
  • 狂犬病诊断市场2030：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: VH4MRDIA01_G26Q1

Rabies diagnostics involve identifying the Rabies disease based on observed conditions and symptoms. This preventable viral illness is commonly transmitted through the bite of a rabid animal. Diagnosis of Rabies typically involves locating the rabies virus within any part of the infected animal's brain. In humans, diagnosis includes testing saliva, serum, spinal fluid, and skin biopsies from hair follicles at the back of the neck.

The methods employed in Rabies diagnostics encompass various tests such as fluorescent antibody tests, immunohistochemical tests, amplification methods, histologic examinations, and serology tests. The fluorescent antibody test (FA) is based on detecting rabies virus proteins (antigen) in the tissues of infected animals. Technologies utilized include ELISA/immunohistochemistry, chromatography techniques, PCR, and others. These diagnostics are commonly employed by hospitals, diagnostic centers, cancer palliative care clinics, and diverse end-users, including pharmacies.

Tariffs have affected the rabies diagnostics market by increasing the cost of imported diagnostic kits, reagents, and molecular testing equipment, creating supply chain bottlenecks for PCR, ELISA, and fluorescent antibody test components. Regions like North America and Europe, which rely on imported precision diagnostic tools, are most impacted, particularly in hospital and diagnostic center segments. On the positive side, tariffs encourage local manufacturing and development of cost-effective diagnostic solutions, boosting regional production capabilities.

The rabies diagnostics market research report is one of a series of new reports from The Business Research Company that provides rabies diagnostics market statistics, including rabies diagnostics industry global market size, regional shares, competitors with a rabies diagnostics market share, detailed rabies diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the rabies diagnostics industry. This rabies diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The rabies diagnostics market size has grown strongly in recent years. It will grow from $1.78 billion in 2025 to $1.89 billion in 2026 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to high prevalence of rabies in animals, increasing awareness of rabies prevention, growth of veterinary diagnostic laboratories, government initiatives for rabies control, advancement in diagnostic reagents and kits.

The rabies diagnostics market size is expected to see strong growth in the next few years. It will grow to $2.45 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to adoption of ai-powered diagnostic tools, rising demand for rapid point-of-care tests, expansion of mobile-based disease surveillance, innovation in molecular and serology techniques, increasing public-private collaborations for rabies eradication. Major trends in the forecast period include rapid point-of-care rabies testing, advanced molecular diagnostic techniques, integration of ai in rabies detection, mobile-based rabies surveillance solutions, high-sensitivity serology testing.

The rising prevalence of rabies is expected to drive growth in the rabies diagnostics market. Rabies is a preventable viral disease most commonly transmitted through the bite of a rabid animal. The virus attacks the central nervous system of mammals, eventually causing brain damage and death. Rabies diagnostics are used to detect the presence of the rabies virus in humans and animals through various tests and techniques. Additionally, the increasing incidence of infectious diseases transmitted by animals has further boosted demand for rabies diagnostics. For example, in April 2024, according to the South Dakota Department of Health (SD DOH), a US-based government agency, South Dakota reported 20 animals testing positive for rabies in 2023, representing a 122% increase compared with 9 cases in 2022. Among the rabid animals, one was a domestic animal (a cow) and the remaining 19 were wild animals, including 18 bats and 1 skunk. Therefore, the growing prevalence of rabies is expected to propel the rabies diagnostics market.

Leading players in the rabies diagnostics market are developing innovative products, such as rabies antibody test kits, to maintain their market position. Rabies antibody test kits are diagnostic tools that detect antibodies in the blood to evaluate immunity or the need for additional rabies vaccination. For example, in February 2024, BioStone Animal Health, a US-based diagnostic company, launched AsurDx. The kit detects antibodies specific to the rabies virus in mammalian serum using a rapid and sensitive ELISA method. It provides a cost-effective solution for assessing rabies immunity in both vaccinated animals and those at risk. The kit is user-friendly, delivers reliable results, and ensures animals meet the standard of 0.5 international units (IU) per ml for protective immunity against rabies.

In November 2025, Zoetis Inc., a US-based provider of animal health medicines, vaccines, and veterinary diagnostic services, acquired Veterinary Pathology Group (VPG) for an undisclosed amount. Through this acquisition, Zoetis expanded its veterinary diagnostics capabilities in the United Kingdom and Ireland, enhancing its laboratory services, including rabies and other infectious disease testing, and improving its ability to deliver faster and more accurate diagnostic insights to veterinary professionals. Veterinary Pathology Group is a UK-based provider of multi-specialty veterinary diagnostic laboratory services, offering a wide range of tests to support clinical decision-making in animal health, including those relevant to rabies surveillance and diagnosis.

Major companies operating in the rabies diagnostics market are Bio-Rad Laboratories Inc., The Merck Group, Aviva Systems Biology Corporation, Creative Diagnostics, Demeditec Diagnostics GmbH, Abbexa Ltd., Norgen Biotek Corp., BioNote Inc., Express Biotech International Inc., MyBioSource Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies Inc., Fluidigm Corp., Bio-X Diagnostics S.A., Fujirebio Diagnostics Inc., Gold Standard Diagnostics Corp., Heska Corporation, IDEXX Laboratories Inc., InBios International Inc., KHB Shanghai Kehua Bio-Engineering Co. Ltd., Meridian Bioscience Inc., MP Biomedicals LLC, Neogen Corporation, Randox Laboratories Ltd., SDIX LLC, Sigma-Aldrich Corporation

North America was the largest region in the rabies diagnostics market in 2025. The regions covered in the rabies diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the rabies diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The rabies diagnostics market includes revenues earned by entities by providing diagnostic services such as reverse transcription followed by polymerase chain reaction (RT-PCR), virus isolation, and direct fluorescent antibody (DFA) tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Rabies Diagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses rabies diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for rabies diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The rabies diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Diagnostic Method: Fluorescent Antibody Test; Immunohistochemical Test; Amplification Methods; Histologic Examination; Serology Tests
  • 2) By Technology: ELISA Or Immunohistochemistry; Chromatography Techniques; PCR; Other Technologies
  • 3) By End-User: Hospital; Diagnostic Centers; Cancer Palliative Care Clinics; Other End-Users
  • Subsegments:
  • 1) By Fluorescent Antibody Test: Direct Fluorescent Antibody Test (DFA)
  • 2) By Immunohistochemical: Enzyme-Linked Immunosorbent Assay (ELISA); Western Blotting
  • 3) By Amplification Methods: Polymerase Chain Reaction (PCR); Reverse Transcription PCR (RT-PCR)
  • 4) By Histologic Examination: Microscopic Examination; Tissue Staining Techniques
  • 5) By Serology Tests: Virus Neutralization Test (VNT); Enzyme-Linked Immunosorbent Assay (ELISA)
  • Companies Mentioned: Bio-Rad Laboratories Inc.; The Merck Group; Aviva Systems Biology Corporation; Creative Diagnostics; Demeditec Diagnostics GmbH; Abbexa Ltd.; Norgen Biotek Corp.; BioNote Inc.; Express Biotech International Inc.; MyBioSource Inc.; QIAGEN N.V.; Thermo Fisher Scientific Inc.; F. Hoffmann-La Roche Ltd.; Agilent Technologies Inc.; Fluidigm Corp.; Bio-X Diagnostics S.A.; Fujirebio Diagnostics Inc.; Gold Standard Diagnostics Corp.; Heska Corporation; IDEXX Laboratories Inc.; InBios International Inc.; KHB Shanghai Kehua Bio-Engineering Co. Ltd.; Meridian Bioscience Inc.; MP Biomedicals LLC; Neogen Corporation; Randox Laboratories Ltd.; SDIX LLC; Sigma-Aldrich Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Rabies Diagnostics Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Rabies Diagnostics Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Rabies Diagnostics Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Rabies Diagnostics Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Rapid Point-Of-Care Rabies Testing
    • 4.2.2 Advanced Molecular Diagnostic Techniques
    • 4.2.3 Integration Of Ai In Rabies Detection
    • 4.2.4 Mobile-Based Rabies Surveillance Solutions
    • 4.2.5 High-Sensitivity Serology Testing

5. Rabies Diagnostics Market Analysis Of End Use Industries

  • 5.1 Hospital
  • 5.2 Diagnostic Centers
  • 5.3 Cancer Palliative Care Clinics
  • 5.4 Research Laboratories
  • 5.5 Veterinary Clinics

6. Rabies Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Rabies Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Rabies Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Rabies Diagnostics Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Rabies Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Rabies Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Rabies Diagnostics Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Rabies Diagnostics Market Segmentation

  • 9.1. Global Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Fluorescent Antibody Test, Immunohistochemical Test, Amplification Methods, Histologic Examination, Serology Tests
  • 9.2. Global Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • ELISA Or Immunohistochemistry, Chromatography Techniques, PCR, Other Technologies
  • 9.3. Global Rabies Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospital, Diagnostic Centers, Cancer Palliative Care Clinics, Other End-Users
  • 9.4. Global Rabies Diagnostics Market, Sub-Segmentation Of Fluorescent Antibody Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Direct Fluorescent Antibody Test (DFA)
  • 9.5. Global Rabies Diagnostics Market, Sub-Segmentation Of Immunohistochemical, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting
  • 9.6. Global Rabies Diagnostics Market, Sub-Segmentation Of Amplification Methods, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymerase Chain Reaction (PCR), Reverse Transcription PCR (RT-PCR)
  • 9.7. Global Rabies Diagnostics Market, Sub-Segmentation Of Histologic Examination, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Microscopic Examination, Tissue Staining Techniques
  • 9.8. Global Rabies Diagnostics Market, Sub-Segmentation Of Serology Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Virus Neutralization Test (VNT), Enzyme-Linked Immunosorbent Assay (ELISA)

10. Rabies Diagnostics Market Regional And Country Analysis

  • 10.1. Global Rabies Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Rabies Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Rabies Diagnostics Market

  • 11.1. Asia-Pacific Rabies Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Rabies Diagnostics Market

  • 12.1. China Rabies Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Rabies Diagnostics Market

  • 13.1. India Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Rabies Diagnostics Market

  • 14.1. Japan Rabies Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Rabies Diagnostics Market

  • 15.1. Australia Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Rabies Diagnostics Market

  • 16.1. Indonesia Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Rabies Diagnostics Market

  • 17.1. South Korea Rabies Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Rabies Diagnostics Market

  • 18.1. Taiwan Rabies Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Rabies Diagnostics Market

  • 19.1. South East Asia Rabies Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Rabies Diagnostics Market

  • 20.1. Western Europe Rabies Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Rabies Diagnostics Market

  • 21.1. UK Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Rabies Diagnostics Market

  • 22.1. Germany Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Rabies Diagnostics Market

  • 23.1. France Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Rabies Diagnostics Market

  • 24.1. Italy Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Rabies Diagnostics Market

  • 25.1. Spain Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Rabies Diagnostics Market

  • 26.1. Eastern Europe Rabies Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Rabies Diagnostics Market

  • 27.1. Russia Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Rabies Diagnostics Market

  • 28.1. North America Rabies Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Rabies Diagnostics Market

  • 29.1. USA Rabies Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Rabies Diagnostics Market

  • 30.1. Canada Rabies Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Rabies Diagnostics Market

  • 31.1. South America Rabies Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Rabies Diagnostics Market

  • 32.1. Brazil Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Rabies Diagnostics Market

  • 33.1. Middle East Rabies Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Rabies Diagnostics Market

  • 34.1. Africa Rabies Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Rabies Diagnostics Market Regulatory and Investment Landscape

36. Rabies Diagnostics Market Competitive Landscape And Company Profiles

  • 36.1. Rabies Diagnostics Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Rabies Diagnostics Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Rabies Diagnostics Market Company Profiles
    • 36.3.1. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. The Merck Group Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Aviva Systems Biology Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Creative Diagnostics Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Demeditec Diagnostics GmbH Overview, Products and Services, Strategy and Financial Analysis

37. Rabies Diagnostics Market Other Major And Innovative Companies

  • Abbexa Ltd., Norgen Biotek Corp., BioNote Inc., Express Biotech International Inc., MyBioSource Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies Inc., Fluidigm Corp., Bio-X Diagnostics S.A., Fujirebio Diagnostics Inc., Gold Standard Diagnostics Corp., Heska Corporation, IDEXX Laboratories Inc.

38. Global Rabies Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Rabies Diagnostics Market

40. Rabies Diagnostics Market High Potential Countries, Segments and Strategies

  • 40.1 Rabies Diagnostics Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Rabies Diagnostics Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Rabies Diagnostics Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer